0001179110-11-011840.txt : 20110808
0001179110-11-011840.hdr.sgml : 20110808
20110808104620
ACCESSION NUMBER: 0001179110-11-011840
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110805
FILED AS OF DATE: 20110808
DATE AS OF CHANGE: 20110808
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Davis Thomas Andrew
CENTRAL INDEX KEY: 0001338185
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15006
FILM NUMBER: 111016010
MAIL ADDRESS:
STREET 1: 65 WEST WATKINS MILL ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celldex Therapeutics, Inc.
CENTRAL INDEX KEY: 0000744218
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 133191702
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 119 FOURTH AVE
CITY: NEEDHAM
STATE: MA
ZIP: 02494
BUSINESS PHONE: 7814330771
MAIL ADDRESS:
STREET 1: 119 FOURTH AVE
CITY: NEEDHAM
STATE: MA
ZIP: 02494-2725
FORMER COMPANY:
FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19980828
FORMER COMPANY:
FORMER CONFORMED NAME: T CELL SCIENCES INC
DATE OF NAME CHANGE: 19920703
4
1
edgar.xml
FORM 4 -
X0304
4
2011-08-05
0
0000744218
Celldex Therapeutics, Inc.
CLDX
0001338185
Davis Thomas Andrew
C/O CELLDEX THERAPEUTICS, INC.
119 FOURTH AVENUE
NEEDHAM
MA
02494
0
1
0
0
Sr. VP & CMO
Incentive Stock Option
2.80
2011-08-05
4
A
0
104500
2.80
A
2012-08-05
2021-08-05
Common Stock
104500
104500
D
25% vest on August 5, 2012 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.
Thomas A. Davis
2011-08-08